Загрузка...
Pharmacological Inhibition of GPR4 remediates intestinal inflammation in a mouse colitis model
Inflammatory bowel disease (IBD) is characterized by chronic, recurring inflammation of the digestive tract. Current therapeutic approaches are limited and include biologics and steroids such as anti-TNFα monoclonal antibodies and corticosteroids, respectively. Significant adverse drug effects can o...
Сохранить в:
| Опубликовано в: : | Eur J Pharmacol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6526936/ https://ncbi.nlm.nih.gov/pubmed/30930250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2019.03.038 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|